Key result
Emergent pericardiocentesis draining ~200 ml and chemotherapy stabilize cardiac tamponade from undiagnosed T-ALL.
Why the study?
T-lymphoblastic leukemia/lymphoma (T-ALL/LBL) is a rare, aggressive hematologic malignancy in young adults that typically presents with a mediastinal mass or bone marrow involvement rather than initial pericardial tamponade.
Case Report (n=1)
No
Pericardial tamponade may be the first manifestation of T-lymphoblastic leukemia/lymphoma, highlighting the need to consider underlying malignancy in unexplained pericardial effusions.
Answers are grounded in this paper and cite their sources.
Supports malignancy evaluation in unexplained tamponade; hypothesis-generating for atypical T-ALL/LBL presentations.
Background: T-lymphoblastic leukemia/lymphoma (T-ALL/LBL) is a rare, aggressive hematologic malignancy that typically affects young adults and often presents with a mediastinal mass or bone marrow involvement. Case presentation: A 35-year-old male with no prior medical history presented with progressive shortness of breath, dry cough, fever, night sweats, and weight loss. He was tachycardic and in respiratory distress, with jugular venous distention and muffled heart sounds. Imaging revealed a large anterior mediastinal mass with pleural and pericardial effusions. Echocardiography confirmed tamponade physiology, prompting emergent pericardiocentesis, which drained 200 ml of fluid; cytology suggested a lymphoid malignancy. Subsequent CT, PET/CT, and tissue studies confirmed T-ALL/LBL without bone marrow involvement. He began chemotherapy and was discharged in stable condition. Conclusion: Although rare, T-ALL/LBL should be considered in unexplained pericardial effusions. Key Clinical MessagePericardial tamponade may be the first manifestation of T-lymphoblastic leukemia/lymphoma. Clinicians should maintain a high index of suspicion for underlying malignancy in unexplained pericardial effusions to enable prompt diagnosis and life-saving intervention. Early multidisciplinary management is crucial to improve outcomes in such rare and aggressive presentations.
No takes yet. Share an insight, caveat, or question.
Rhabneh et al. (2026) conducted a case report in T-lymphoblastic leukemia/lymphoma presenting as pericardial tamponade (n=1). Emergent pericardiocentesis and chemotherapy was evaluated on Clinical stabilization and hospital discharge. Emergent pericardiocentesis (draining 200 ml) and chemotherapy stabilized a 35-year-old man presenting with cardiac tamponade as the first sign of T-lymphoblastic leukemia/lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: